The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized, double-blind phase III study of pazopanib versus placebo in patients with metastatic renal cell carcinoma who have no evidence of disease following metastasectomy: A trial of the ECOG-ACRIN cancer research group (E2810).
Leonard Joseph Appleman
Research Funding - Acerta Pharma (Inst); Agensys (Inst); Astellas Pharma (Inst); AVEO (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Inovio Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seattle Genetics (Inst); Tokai Pharmaceuticals (Inst)
Maneka Puligandla
No Relationships to Disclose
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
Wayne Harris
No Relationships to Disclose
Neeraj Agarwal
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; EMD Serono; Exelixis; Foundation One Inc; Genentech/Roche; Lilly; Medivation/Astellas; Merck; Nektar; Novartis; Pfizer; Pharmacyclics
Research Funding - Active Biotech (Inst); Amgen (Inst); AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Takeda (Inst); TRACON Pharma (Inst)
Brian Addis Costello
Research Funding - GlaxoSmithKline/Novartis (Inst)
Christopher W. Ryan
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Novartis; Pfizer
Research Funding - Argos Therapeutics (Inst); Bristol-Myers Squibb (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline/Novartis (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MabVax (Inst); Merck (Inst); Morphotek (Inst); Pfizer (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst)
Michael Pins
Speakers' Bureau - Genentech/Roche; Merck
Jill Kolesar
Stock and Other Ownership Interests - Helix Diagnostics
Daniel A. Vaena
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exelixis
Research Funding - Aeglea Biotherapeutics (Inst); AstraZeneca (Inst); BioClin Therapeutics (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Compugen (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Peloton Therapeutics (Inst); TG Therapeutics (Inst); Tizona Therapeutics, Inc. (Inst)
Travel, Accommodations, Expenses - Caris Centers of Excellence; Genomic Health
Rahul Atul Parikh
Stock and Other Ownership Interests - Immunomedics (I)
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Seattle Genetics/Astellas
Research Funding - Saladax Biomedical; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - Patents on DNA repair pathways in cancer. I do not receive any royalties for the same.
Travel, Accommodations, Expenses - AstraZeneca; Seattle Genetics
Mehmood Hashmi
No Relationships to Disclose
Janice P. Dutcher
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Medarex; Eisai; Merck; Nektar; Prometheus; TRACON Pharma
Speakers' Bureau - Prometheus
Travel, Accommodations, Expenses - Prometheus
Robert S. DiPaola
No Relationships to Disclose
Naomi B. Haas
Consulting or Advisory Role - Cerulean Pharma; Exelixis; Janssen Oncology; Novartis; Pfizer
Expert Testimony - Lilly (I)
Michael Anthony Carducci
Consulting or Advisory Role - Abbvie; Astellas Pharma; Foundation Medicine; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); eFFECTOR Therapeutics (Inst); EMD Serono (Inst); Gilead Sciences (Inst); pfizer (Inst)